KADMON HOLDINGS, INC.
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 92.59B | ||||||
| 41.43B | ||||||
| 33.49B | ||||||
| 14.62B | ||||||
| 12.77B |
